This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
NanoViricides (NNVC) is weeks away from first patient dosing in a Phase II trial of NV-387 Oral Gummies for Ebola treatment in the DRC, following regulatory approval from local agency ACOREP. #Ebola #Antiviral
2026-08-18T17:01:26.974Z